PsychoGenics, Inc.

PsychoGenics is a preclinical Contract Research Organization with expertise in central nervous system and orphan disorders. Their mission is to provide the best validated disease models and comprehensive preclinical capabilities to help researchers discover the next breakthroughs for severely disabling central nervous system and orphan disorders and reduce the attrition rate in clinical development.

PsychoGenics has been working with CMTA for over 10 years. They work to breed and maintain several mouse and rat models of CMT1A, 2A and 2E. Additionally, they evaluate potential novel therapeutics (small molecules, gene therapy, biologics and others) for efficacy and tolerability in these rodent models.